This record was last updated January 13, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
This clinical trial is a randomized, double-blind, placebo-controlled, single ascending dose, phase 1 clinical trial to evaluate the safety/tolerability and pharmacokinetic characteristics, and to explore food effect and ethnic difference of JW2286 after oral administration in healthy adults.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-21.
Status change: Not Yet Recruiting → Recruiting2025-01-09